SCHEMBL5634864

SCHEMBL5634864

CCCCN1C(=O)C(=C2SCCCS2)C(=O)N(CCCCCc2ccccc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
MAPT P10636 3/20 0.45
MEN1 O00255 2/20 0.45
USP2 O75604 2/20 0.45
POLB P06746 2/20 0.45
RECQL P46063 2/20 0.45
BLM P54132 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
THRB P10828 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP2C19 P33261 1/20 0.45
GSK3A P49840 2/20 0.45
GSK3B P49841 2/20 0.45
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5632662 0.99 L3MBTL1 (0.48) TDP1L3MBTL1MAPTMEN1USP2
SCHEMBL5634261 0.84 ALDH1A1 (0.38) TDP1L3MBTL1MAPTMEN1USP2
SCHEMBL5634048 0.78 HTT (0.44) L3MBTL1MAPTMEN1KMT2ALMNA
SCHEMBL5634473 0.76 L3MBTL1 (0.38) TDP1L3MBTL1MAPTMEN1USP2
SCHEMBL5634590 0.76 EPHX2 (0.42) TDP1L3MBTL1MAPTMEN1KMT2A
SCHEMBL5633117 0.75 GRM5 (0.47) MAPTMEN1KMT2ANPC1TP53
SCHEMBL5442584 0.75 MAPT (0.67) TDP1L3MBTL1MAPTMEN1USP2
SCHEMBL5633809 0.75 TDP1 (0.56) TDP1L3MBTL1MAPTMEN1USP2
SCHEMBL5633394 0.74 ALDH1A1 (0.31) TDP1L3MBTL1MAPTMEN1USP2
SCHEMBL5633937 0.73 TDP1 (0.54) TDP1L3MBTL1MAPTMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123548-A1 Pth agonists COWAN DAVID J 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123548-A1 Pth agonists PTH1R, SSTR3, CALCR TDP1 4833/4885L3MBTL1 4667/4885MAPT 4835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.